[go: up one dir, main page]

JP2000044481A - Preparation for external use for skin - Google Patents

Preparation for external use for skin

Info

Publication number
JP2000044481A
JP2000044481A JP10230069A JP23006998A JP2000044481A JP 2000044481 A JP2000044481 A JP 2000044481A JP 10230069 A JP10230069 A JP 10230069A JP 23006998 A JP23006998 A JP 23006998A JP 2000044481 A JP2000044481 A JP 2000044481A
Authority
JP
Japan
Prior art keywords
extract
skin
plant
preparation
external use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10230069A
Other languages
Japanese (ja)
Inventor
Motonobu Matsumoto
元伸 松本
Yasunobu Kobayashi
泰信 小林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunstar Inc
Original Assignee
Sunstar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunstar Inc filed Critical Sunstar Inc
Priority to JP10230069A priority Critical patent/JP2000044481A/en
Publication of JP2000044481A publication Critical patent/JP2000044481A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a preparation for external use for skin having excellent inflammation inhibitory activity and itch inhibitory activity by formulating a combination of each specific plant extract. SOLUTION: This preparation for external use for skin contains a combination of at least one kind of extract derived from plant(s) selected from Sophora angustifolia, lmpatience balsamina L. and peppermint with at least another kind of extract derived from plant(s) selected from Artemisia princeps, Ligusticum acutilobum, Sanguisorba officinalis, root of Glycyrrhiza glabra, Aloe, Luffa cylindrica, root of Scutellaria baicalensis, sea algae, Matricaria chamomilla, Cape jasmine, Sasa albo-marginata, Morus alba, Perilla frutescens crispa, Betula tauschii, Equisetum arvense, Achillea milefolium, carrot, Hamamelis virginiana L., rose, Aesculus hippocastanum, Ganoderma lucidum, Calendula officinalis, rosemary, apple, Hedera helix, Coix lachrymajobi, peach, Prunus armeniaca, Paeonia lactiflora, rhizome of Zingiber officinale, Kochia scoparia, and peony.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、特定植物の抽出エ
キスを組み合わせて配合することにより、優れた炎症抑
制作用、ならびにかゆみ抑制作用を有する、皮膚外用剤
に関する。
TECHNICAL FIELD The present invention relates to an external preparation for skin having an excellent inflammation-suppressing action and an itching-inhibiting action when combined with extracts of specific plants.

【0002】[0002]

【従来技術と課題】近年、アトピー性皮膚炎や老人性掻
痒症などの皮膚疾患が問題とされており、その患者は年
々増えている。これら皮膚疾患は、かゆみを伴う疾患と
して知られているが、かゆみが患者に精神的に苦痛を与
えるとともに、掻く事により症状を悪化させてしまう。
これらの皮膚疾患の予防または治療すべく、各種の外用
剤が提案されている。例えば、副腎皮質ホルモンは優れ
た抗炎症剤であり、疾患に対して優れた炎症抑制効果、
かゆみ抑制効果を有するものの、副作用面での懸念があ
り、満足のできる治療薬とは言い難い。また、皮膚に対
する作用が緩和なものとして、植物エキスを用いること
も考えられており、かゆみ・炎症を抑制するものとして
提案されている。
2. Description of the Related Art In recent years, skin diseases such as atopic dermatitis and senile pruritus have been regarded as problems, and the number of patients has been increasing year by year. These skin diseases are known as itch-related diseases, but itching causes mental discomfort to the patient and worsens the symptoms by scratching.
In order to prevent or treat these skin diseases, various external preparations have been proposed. For example, corticosteroids are excellent anti-inflammatory agents and have excellent anti-inflammatory effects on diseases,
Although it has an itching-suppressing effect, there are concerns about side effects, and it is hard to say that it is a satisfactory therapeutic agent. It is also considered to use a plant extract as a substance having a mild effect on the skin, and it has been proposed to suppress itching and inflammation.

【0003】[0003]

【課題を解決するための手段】本発明者らは、かゆみと
炎症の抑制に有効な、天然由来の薬剤を鋭意検討した。
すなわち、かゆみの誘発物質としては、ヒスタミンがよ
く知られており、ヒスタミンが肥満細胞の脱顆粒により
組織内に遊離し、かゆみを起こし、これが炎症の起こる
初期反応であることから、本発明者らは、種々の植物エ
キスについてヒスタミン遊離抑制作用(in vitr
o)および起炎剤(compound48/80)に対
する抗炎症作用(in vivo)を指標にして探索し
たところ、特定の植物の抽出エキスを併用することによ
り、より優れた炎症抑制作用およびかゆみ抑制作用を発
揮する事を見出し、本発明を完成させるに至った。
Means for Solving the Problems The present inventors diligently studied a naturally occurring drug which is effective in suppressing itch and inflammation.
That is, histamine is well known as an itch-inducing substance, and histamine is released into tissues by degranulation of mast cells, causing itch, which is an initial reaction in which inflammation occurs. Has a histamine release inhibitory effect (in vitro) on various plant extracts.
o) and an anti-inflammatory effect (in vivo) against an inflammatory agent (compound 48/80) were searched for as an index. By using an extract of a specific plant in combination, a more excellent anti-inflammatory and anti-itch effect was obtained. They have found out that they have achieved this, and have completed the present invention.

【0004】[0004]

【発明の実施の形態】すなわち、本発明は、クララ、ホ
ウセンカ、ミントから選ばれる少なくとも1種以上の抽
出エキスと、ヨモギ、当帰、ワレモコウ、カンゾウ、アロ
エ、ヘチマ、オウゴン、海藻、カミツレ、クチナシ、ク
マザサ、クワ、シソ、シラカバ、スギナ、セイヨウノコ
ギリソウ、ニンジン、ハマメリス、バラ、マロニエ、マ
ンネンタケ、トウキセンカ、ローズマリー、リンゴ、セ
イヨウキズク、ハトムギ、モモ、アンズ、シャクヤク、
ショウキョウ、ホウキギ、ボタンピから選ばれる少なく
とも1種以上の抽出エキスとを併用することを特徴とす
る優れた炎症抑制作用およびかゆみ抑制作用を発揮す
る、皮膚外用剤に関する。
DESCRIPTION OF THE PREFERRED EMBODIMENTS That is, the present invention relates to an extract of at least one selected from Clara, Balsam, and mint, as well as mugwort, toki, waremokou, licorice, aloe, luffa, giant gourd, seaweed, chamomile and gardenia. , Kumazasa, Mulberry, Perilla, Birch, Horsetail, Caribbean, Hawberry, Rose, Marronnier, Mannentake, Toukisenka, Rosemary, Apple, Atlantic Owl, Barley, Peach, Apricot, Peony,
The present invention relates to an external preparation for skin, which exhibits an excellent inflammation-suppressing action and itching-suppressing action, characterized in that it is used in combination with at least one or more extracted extracts selected from ginger, pufferfish and buttonpicks.

【0005】本発明に用いられる植物は、全草もしくは
好ましい部位を用いることができる。たとえば、クララ
は根を、ホウセンカは花を、ミントは葉を、ヨモギは葉
を、当帰は根を、ワレモコウは根を、カンゾウは根を、
アロエは葉を、ヘチマは地上部を、オウゴンは根を、カ
ミツレは花を、クチナシは果実を、クマザサは葉を、ク
ワは根を、シソは葉を、シラカバは樹皮を、ニンジンは
根を、ハマメリスは葉、根、樹皮を、バラは花を、マン
ネンタケは子実体を、トウキンセンカは花を、ローズマ
リーは葉または花を、リンゴは果実を、ハトムギは種子
を、モモは種子または果実または葉を、アンズは種子
を、シャクヤクは根を、ショウキョウは根を用いるのが
好ましい。 これらの植物からの抽出エキスは以下の方法で得る事が
できる。 例えば、植物の生または乾燥物を、水または水性有機溶
媒で抽出する。抽出溶媒は通常、原料の2〜5倍容量加
え、2〜3回繰り返し抽出するのが好ましい。抽出は水で
十分に行えるが、抽出液の腐敗防止や、抽出を促進するた
めに水性有機溶媒を用いてもよい。水性有機溶媒として
は、例えば、メタノールやエタノールのような低級アルコ
ールが挙げられる。 また、この抽出は加温によって促進され、原料は破砕もし
くは粉砕するのが好ましい。 尚、これらの成分は、そのままの形で化粧料に配合する
事に何ら問題はないが、必要に応じて脱色や脱臭等の目
的のために活性炭等の処理をおこなってもかまわない。
[0005] The plant used in the present invention may be whole plant or a preferable part. For example, Clara has roots, Balsam has flowers, mint has leaves, mugworts have leaves, Toki has roots, Warm Mocks has roots, Licorice has roots,
Aloe for leaves, loofah for above-ground parts, ogre for roots, chamomile for flowers, gardenia for fruits, Kumazasa for leaves, mulberry for roots, perilla for leaves, birch for bark, carrots for roots. , Hamamelis leaves, roots, bark, roses, flowers, ginseng, fruit bodies, rosemary, flowers, rosemary, leaves or flowers, apples, fruits, adlay seeds, peaches, seeds or fruits. Or leaves, apricots use seeds, peonies use roots, and ginger use roots. Extracts extracted from these plants can be obtained by the following method. For example, a raw or dried plant is extracted with water or an aqueous organic solvent. Usually, it is preferable that the extraction solvent is added 2 to 5 times the volume of the raw material and the extraction is repeated 2 to 3 times. Although extraction can be sufficiently performed with water, an aqueous organic solvent may be used to prevent decay of the extract and to promote extraction. Examples of the aqueous organic solvent include lower alcohols such as methanol and ethanol. This extraction is promoted by heating, and the raw material is preferably crushed or pulverized. It should be noted that there is no problem if these components are incorporated into the cosmetics as they are, but they may be treated with activated carbon or the like for the purpose of decolorization or deodorization as required.

【0006】このようにして得られた特定植物エキスを
併用した皮膚外用剤は、後述のように優れた抗炎症、抗か
ゆみ作用を有し、さらに肌荒れ防止・改善効果にも優れ
た効果を発揮する事が判明した。これらの効果は0.0
01〜20%重量の範囲で配合した時、好ましくは両エ
キスをそれぞれ0.1〜10%重量配合した時に顕著に
認められる。
[0006] The external preparation for skin combined with the specific plant extract thus obtained has an excellent anti-inflammatory and anti-itch effect as described later, and also has an excellent effect of preventing and improving rough skin. It turned out to be. These effects are 0.0
It is remarkably observed when it is blended in the range of 01 to 20% by weight, and preferably when both extracts are blended in the amount of 0.1 to 10% by weight.

【0007】本発明の皮膚外用剤には、植物抽出エキス
に加え、必要に応じ、本発明の効果をそこなわない範囲で
化粧品、医薬部外品、医薬品等に一般に用いられる抗炎症
作用を有する成分、例えば、オキシベンゾン、トラネキサ
ム酸、およびその誘導体、アラントイン、イプシロンアミ
ノカプロン酸、グリチルリチン酸、感光素301号、40
1号、塩酸ジフェンヒドラミン、アデノシン酸、カラミ
ン、水溶性アズレン、アミノカプロン酸、サリチル酸、ビサ
ポロールエキス等の1種または2種以上を配合してもよ
い。
[0007] The external preparation for skin of the present invention has an anti-inflammatory effect commonly used in cosmetics, quasi-drugs, pharmaceuticals, etc., in addition to the plant extract, if necessary, as long as the effects of the present invention are not impaired. Ingredients, for example, oxybenzone, tranexamic acid, and derivatives thereof, allantoin, epsilon aminocaproic acid, glycyrrhizic acid, Photosensitizer No. 301, 40
No. 1, one or two or more of diphenhydramine hydrochloride, adenosine acid, calamine, water-soluble azulene, aminocaproic acid, salicylic acid, and bisapolol extract may be blended.

【0008】さらに本発明の外用剤には、前期の有効成
分に加え、必要に応じ、本発明の効果をそこなわない範囲
で化粧品、医薬部外品、医薬品等に一般に用いられる成
分、例えば界面活性剤、グリセリン、1、3-ブチレングリコ
ール、ヒアルロン酸、セラミド等の保湿剤、紫外線吸収剤
や紫外線散乱剤、また増粘剤、防腐剤、酸化防止剤、香料、
色剤等を配合する事ができる。また本発明の外用剤の剤
系は任意であり、例えば、水溶液系、可溶化系、乳化系、粉
末系、油液系、ゲル系、軟膏系等の剤系で調製する事がで
きる。
The external preparation of the present invention may further contain, in addition to the above-mentioned active ingredients, if necessary, components generally used in cosmetics, quasi-drugs, pharmaceuticals, etc. as long as the effects of the present invention are not impaired. Activators, humectants such as glycerin, 1,3-butylene glycol, hyaluronic acid, ceramide, ultraviolet absorbers and ultraviolet scattering agents, thickeners, preservatives, antioxidants, fragrances,
A coloring agent or the like can be blended. The agent system of the external preparation of the present invention is arbitrary, and for example, it can be prepared in an agent system such as an aqueous solution system, a solubilizing system, an emulsifying system, a powder system, an oil liquid system, a gel system and an ointment system.

【0009】[0009]

【実施例】以下、実験例をあげて、発明の効果を説明す
る。実験例1 <抽出エキスの調製>植物の乾燥物400gを50%(V
/V)エタノール水溶液5リットルに浸漬した後、2時間
加熱還流にて抽出を行った。その後同量のエタノール:
水混液を用いて同様に2時間加熱還流にて抽出を行った
後に、抽出液を濾過して合し、その後減圧下で溶媒留去
により乾固することで、褐色粉末状物質を得た。
EXAMPLES The effects of the present invention will be described below with reference to experimental examples. EXPERIMENTAL EXAMPLE 1 <Preparation of Extract> 400 g of dried plant material was added to 50% (V
/ V) After immersion in 5 liters of an aqueous ethanol solution, extraction was performed by heating under reflux for 2 hours. Then the same amount of ethanol:
After similarly extracting with heating and refluxing for 2 hours using a water mixture, the extracts were combined by filtration, and then evaporated to dryness under reduced pressure to obtain a brown powdery substance.

【0010】<ヒスタミン遊離抑制試験>雄性ラット(W
ister/ST系、体重約150g)を用い、腹腔内に0.1%
BSAリン酸緩衝液を注入し、常法に従って肥満細胞を
分取し、細胞浮遊液を調製した。この浮遊液2mlに前
記抽出エキスを25μg/ml(最終濃度)もしくは50μg/m
l(最終濃度)、もしくは5μg/ml〜25μg/ml(最終濃
度)の範囲で前記抽出エキスを組み合わせて添加した。
前記抽出エキス添加10分後に起炎剤(compoun
d48/80)を添加し、10分間の遊離および細胞内
ヒスタミン量を蛍光法で定量し、数1で示される式に従
って遊離抑制率(%)を算出した。結果を表1に示す。
<Histamine release inhibition test> Male rats (W
ister / ST system, weight about 150g), 0.1% intraperitoneally
BSA phosphate buffer was injected, mast cells were collected according to a conventional method, and a cell suspension was prepared. 25 μg / ml (final concentration) or 50 μg / m
l (final concentration), or a combination of the above extracts in the range of 5 μg / ml to 25 μg / ml (final concentration).
10 minutes after the addition of the extracted extract,
d48 / 80) was added, and the amount of free and intracellular histamine for 10 minutes was quantified by a fluorescence method, and the release inhibition rate (%) was calculated according to the formula shown in Equation 1. Table 1 shows the results.

【0011】[0011]

【数1】 (Equation 1)

【0012】[0012]

【表1】 [Table 1]

【0013】表1に示すように、ホウセンカ、ミント、
クララから選ばれる少なくとも1種以上の抽出エキス
と、ヨモギ、当帰、ワレモコウ、カンゾウ、アロエ、ヘチ
マ、オウゴン、海藻、カミツレ、クチナシ、クマザサ、
クワ、シソ、シラカバ、スギナ、セイヨウノコギリソ
ウ、ニンジン、ハマメリス、バラ、マロニエ、マンネン
タケ、トウキセンカ、ローズマリー、リンゴ、セイヨウ
キズク、ハトムギ、モモ、アンズ、シャクヤク、ショウ
キョウ、ホウキギ、ボタンピから選ばれる少なくとも1
種以上の抽出エキスとを併用した場合、抽出エキスを単
独で、同量用いた場合に比べても、相乗的に、ヒスタミ
ン遊離を抑制することがわかる。
[0013] As shown in Table 1, balsam, mint,
At least one or more extracted extracts selected from Clara, mugwort, toki, waremokou, licorice, aloe, luffa, ougon, seaweed, chamomile, gardenia, kumazasa,
At least one selected from mulberry, perilla, birch, horsetail, Achillea millefolium, carrot, hamamelis, rose, marronnier, mannenthus mushroom, cornflower, rosemary, apple, prunus omelette, barley, peach, apricot, peonies, gingerbread, squirrel, buttonpipi
It can be seen that when more than one kind of extract is used in combination, histamine release is synergistically suppressed as compared with the case where the same amount of extract is used alone.

【0014】<足浮腫抑制試験>2.5重量%もしくは
5.0重量%の前記抽出エキス、もしくは各々を2.5
重量%ずつ混合したエキスを、マクロゴール軟膏に配合
し、これを雄性ラット(Wister/ST系、体重約150g)の
右後足に塗布し、4時間後、同右後足せき皮下に、起炎
剤として生理食塩水に溶解したcompound48/
80を皮下注射した。その30分後に足容積測定装置に
よって腫れ容積を測定し、数2で示される式に従って浮
腫率を算出し、またエキスを配合しないマクロゴール軟
膏を塗布した対照群での浮腫率との比較により数3で示
される式に従って抑制率を算出した。結果を表2に示
す。
<Paw edema inhibition test> 2.5% by weight or 5.0% by weight of the above-mentioned extract or 2.5% by weight of each extract
The extract mixed by weight% was mixed into macrogol ointment, which was applied to the right hind paw of a male rat (Wister / ST system, body weight: about 150 g). Compound48 / dissolved in physiological saline
80 was injected subcutaneously. Thirty minutes later, the swelling volume was measured by a foot volume measuring device, the edema rate was calculated according to the equation shown in Equation 2, and the edema rate was compared with the edema rate in a control group to which Macrogol ointment containing no extract was applied. The suppression rate was calculated according to the formula shown in FIG. Table 2 shows the results.

【0015】[0015]

【数2】 (Equation 2)

【0016】[0016]

【数3】 (Equation 3)

【0017】[0017]

【表2】 [Table 2]

【0018】表2に示すように、ホウセンカ、ミント、
クララから選ばれる少なくとも1種以上の抽出エキス
と、ヨモギ、当帰、ワレモコウ、カンゾウ、アロエ、ヘチ
マ、オウゴン、海藻、カミツレ、クチナシ、クマザサ、
クワ、シソ、シラカバ、スギナ、セイヨウノコギリソ
ウ、ニンジン、ハマメリス、バラ、マロニエ、マンネン
タケ、トウキセンカ、ローズマリー、リンゴ、セイヨウ
キズク、ハトムギ、モモ、アンズ、シャクヤク、ショウ
キョウ、ホウキギ、ボタンピから選ばれる少なくとも1
種以上の抽出エキスとを併用した場合、抽出エキスを単
独で、同量用いた場合に比べても、相乗的に、足浮腫を
抑制することがわかる。さらに、実施例1の軟膏を肌荒
れを起こしている人の皮膚に塗布した場合、肌荒れ改善
効果があることも確認された。
As shown in Table 2, the balsam, mint,
At least one or more extracted extracts selected from Clara, mugwort, toki, waremokou, licorice, aloe, luffa, ougon, seaweed, chamomile, gardenia, kumazasa,
At least one selected from mulberry, perilla, birch, horsetail, Achillea millefolium, carrot, hamamelis, rose, marronnier, mannentake, toukisenka, rosemary, apple, prunus sylvestris, barley, peach, apricot, peonies, gingerbread, squirrel, buttonpipi
It can be seen that when more than one kind of extract is used in combination, paw edema is synergistically suppressed as compared with the case where the same amount of extract is used alone. Furthermore, it was also confirmed that when the ointment of Example 1 was applied to the skin of a person having rough skin, there was an effect of improving the rough skin.

【0019】実施例27:軟膏 成分 配合量(重量%) ヨモギエキス 2.5 クララエキス 2.5 プロピレングリコール#400 15.0 マクロゴール軟膏 80.0 実験例1で得たヨモギエキスおよびクララエキスをプロ
ピレングリコール#400に均一に分散させた後、マクロゴ
ール軟膏を加えて混合する。
Example 27: Ointment Ingredients Compounding amount (% by weight) Artemisia extract 2.5 Clara extract 2.5 Propylene glycol # 400 15.0 Macrogol ointment 80.0 The artemisia extract and Clara extract obtained in Experimental example 1 are uniformly dispersed in propylene glycol # 400. After that, macrogol ointment is added and mixed.

【0020】 実施例28:軟膏 成分 配合量(重量%) バラエキス 1.5 ヨモギエキス 1.0 ホウセンカエキス 2.5 プロピレングリコール#400 15.0 マクロゴール軟膏 80.0 実験例1で得たバラエキスおよびヨモギエキスおよびホ
ウセンカエキスをプロピレングリコール#400に均一に分
散させた後、マクロゴール軟膏を加えて混合する。
Example 28: Ointment Ingredients Compounding amount (% by weight) Rose extract 1.5 Artemisia extract 1.0 Balsam extract 2.5 Propylene glycol # 400 15.0 Macrogol ointment 80.0 The rose extract, artemisia extract and artemisia extract obtained in Experimental Example 1 were converted to propylene glycol # 400. And then add Macrogol ointment and mix.

【0021】 実施例29:化粧水 成分 配合量(重量%) ヨモギエキス 1.0 海藻エキス 1.0 マンネンタケエキス 1.0 ミントエキス 1.0 クララエキス 1.0 グリセリン 6.0 エタノール 9.0 ポリオキシエチレン硬化ヒマシ油 0.8 メチルパラベン 0.05 クエン酸 0.05 クエン酸ナトリウム 0.07 香料 0.1 精製水 残部 合計 100.0 精製水にグリセリン、クエン酸、クエン酸ナトリウム、
実験例1で得たヨモギエキスおよび海藻エキスおよびマ
ンネンタケエキスおよびミントエキスおよびクララエキ
スを溶解する。個別にエタノールにポリオキシエチレン
硬化ヒマシ油(60.E.O.)、メチルパラベン、香料を溶解
し、前記の水溶液に加えて可溶化し、濾過して化粧水を
得た。
Example 29: Lotion lotion component content (% by weight) mugwort extract 1.0 seaweed extract 1.0 mannentake extract 1.0 mint extract 1.0 clara extract 1.0 glycerin 6.0 ethanol 9.0 polyoxyethylene hydrogenated castor oil 0.8 methyl paraben 0.05 citric acid 0.05 sodium citrate 0.07 Fragrance 0.1 Purified water Remainder Total 100.0 Glycerin, citric acid, sodium citrate,
The mugwort extract, seaweed extract, ginseng extract, mint extract and Clara extract obtained in Experimental Example 1 are dissolved. Polyoxyethylene hydrogenated castor oil (60.EO), methyl paraben, and fragrance were individually dissolved in ethanol, added to the above aqueous solution, solubilized, and filtered to obtain a lotion.

【0022】 実施例30:化粧水 成分 配合量(重量%) シャクヤクエキス 1.0 リンゴエキス 1.0 マンネンタケエキス 1.0 クララエキス 1.0 ホウセンカエキス 1.0 グリセリン 6.0 エタノール 9.0 ポリオキシエチレン硬化ヒマシ油 0.8 メチルパラベン 0.05 クエン酸 0.05 クエン酸ナトリウム 0.07 香料 0.1 精製水 残部 合計 100.0 精製水にグリセリン、クエン酸、クエン酸ナトリウム、
実験例1で得たシャクヤクエキスおよびリンゴエキスお
よびマンネンタケエキスおよびクララエキスおよびホウ
センカエキスを溶解する。個別にエタノールにポリオキ
シエチレン硬化ヒマシ油(60.E.O.)、メチルパラベン、
香料を溶解し、前記の水溶液に加えて可溶化し、濾過し
て化粧水を得た。
Example 30: Lotion Component Ingredients Amount (wt%) Peony Extract 1.0 Apple Extract 1.0 Mannentake Extract 1.0 Clara Extract 1.0 Datura Extract 1.0 Glycerin 6.0 Ethanol 9.0 Polyoxyethylene Hardened Castor Oil 0.8 Methylparaben 0.05 Citric Acid 0.05 Sodium Citrate 0.07 Fragrance 0.1 Purified water Remainder Total 100.0 Glycerin, citric acid, sodium citrate,
The peony extract, the apple extract, the Ganoderma lucidum extract, the Clara extract and the balsam pear extract obtained in Experimental Example 1 are dissolved. Polyoxyethylene hydrogenated castor oil (60.EO), methyl paraben,
The fragrance was dissolved, added to the aqueous solution to solubilize, and filtered to obtain a lotion.

【0023】 実施例31:クリーム 成分 配合量(重量%) 成分(A) ポリグリセリン脂肪酸エステル 4.0 セタノール 2.0 ステアリン酸 1.0 ミリスチン酸イソプロピル 5.0 オリーブ油 2.0 スクワラン 9.0 自己乳化型モノステアリン酸グリセリル 3.0 パラベン 0.3 成分(B) モモエキス 0.5 アロエエキス 0.5 クララエキス 0.5 ミントエキス 0.5 グリセリン 5.0 トリメチルグリシン 1.0 香料 0.2 精製水 残部 成分(C) 水酸化カリウム水溶液 3.0 (精製水にて100%に調製) 成分(A)を加熱溶解し、80℃にする。別に香料を除
く成分(B)を加熱溶解して80℃に保ち、これに前記
成分(A)を撹拌しながら加えて、充分混合する。さら
に成分(C)を加え、撹拌しながら冷却を行い、香料を
加え、さらに混合してクリームを得た。
Example 31: Cream Ingredients Compounding amount (% by weight) Ingredient (A) Polyglycerin fatty acid ester 4.0 Cetanol 2.0 Stearic acid 1.0 Isopropyl myristate 5.0 Olive oil 2.0 Squalane 9.0 Self-emulsifying glyceryl monostearate 3.0 Paraben 0.3 Ingredient (B Peach extract 0.5 Aloe extract 0.5 Clara extract 0.5 Mint extract 0.5 Glycerin 5.0 Trimethylglycine 1.0 Fragrance 0.2 Purified water Remaining component (C) Potassium hydroxide aqueous solution 3.0 (prepared to 100% with purified water) Heat and dissolve component (A), Bring to 80 ° C. Separately, the component (B) excluding the fragrance is dissolved by heating and kept at 80 ° C., and the component (A) is added thereto with stirring and mixed well. Further, the component (C) was added, the mixture was cooled with stirring, a flavor was added, and the mixture was further mixed to obtain a cream.

【0024】 実施例32:クリーム 成分 配合量(重量%) 成分(A) ポリグリセリン脂肪酸エステル 4.0 セタノール 2.0 ステアリン酸 1.0 ミリスチン酸イソプロピル 5.0 オリーブ油 2.0 スクワラン 9.0 自己乳化型モノステアリン酸グリセリル 3.0 パラベン 0.3 成分(B) ハトムギエキス 0.5 シラカバエキス 0.5 オウゴンエキス 0.5 ホウセンカエキス 0.5 ミントエキス 0.5 グリセリン 5.0 トリメチルグリシン 1.0 香料 0.2 精製水 残部 成分(C) 水酸化カリウム水溶液 3.0 (精製水にて100%に調製) 成分(A)を加熱溶解し、80℃にする。別に香料を除
く成分(B)を加熱溶解して80℃に保ち、これに前記
成分(A)を撹拌しながら加えて、充分混合する。さら
に成分(C)を加え、撹拌しながら冷却を行い、香料を
加え、さらに混合してクリームを得た。
Example 32: Cream Ingredients Compounding amount (% by weight) Ingredient (A) Polyglycerin fatty acid ester 4.0 Cetanol 2.0 Stearic acid 1.0 Isopropyl myristate 5.0 Olive oil 2.0 Squalane 9.0 Self-emulsifying glyceryl monostearate 3.0 Paraben 0.3 Ingredient (B ) Barley extract 0.5 Birch extract 0.5 Japanese gourd extract 0.5 Balsam pear extract 0.5 Mint extract 0.5 Glycerin 5.0 Trimethylglycine 1.0 Perfume 0.2 Purified water Remaining component (C) Potassium hydroxide aqueous solution 3.0 (prepared to 100% with purified water) Component (A) Heat and melt to 80 ° C. Separately, the component (B) excluding the fragrance is dissolved by heating and kept at 80 ° C., and the component (A) is added thereto with stirring and mixed well. Further, the component (C) was added, the mixture was cooled with stirring, a flavor was added, and the mixture was further mixed to obtain a cream.

【0025】[0025]

【発明の効果】本発明で得られた皮膚外用剤は、優れた
抗炎症、抗かゆみ作用を有し、アトピー性皮膚炎や老人
性掻痒症をはじめとするカユミや炎症を伴なう皮膚症状
を緩和し、その改善に効果を発揮する。さらに、得られ
た皮膚外用剤は、優れた肌荒れ改善に有効であった。
The external preparation for skin obtained by the present invention has an excellent anti-inflammatory and anti-itch effect, and skin symptoms accompanied by inflammation and inflammation such as atopic dermatitis and senile pruritus. To alleviate and improve the effect. Furthermore, the obtained external preparation for skin was effective for excellent skin roughness improvement.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) // A61K 9/06 A61K 9/06 G Fターム(参考) 4C076 AA08 AA12 BB31 CC18 DD37E DD38E DD38F DD43E EE23 EE23A EE54 EE54A EE54E EE58A FF15 FF16 4C083 AA031 AA032 AA111 AA112 AA122 AC022 AC072 AC102 AC122 AC242 AC302 AC352 AC422 AC432 AC482 AC582 AD042 CC03 CC04 CC05 DD22 DD23 DD27 DD31 EE11 EE13 4C088 AA06 AA12 AA18 AB12 AB14 AB16 AB18 AB19 AB25 AB26 AB29 AB32 AB34 AB38 AB40 AB41 AB51 AB52 AB58 AB59 AB60 AB76 AB77 AB81 AB86 AC01 AC02 AC03 AC04 AC05 AC06 AC11 AC13 AC17 BA04 BA05 BA09 BA10 MA07 MA63 NA14 ZA89 ZB11 ZC13 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI theme coat ゛ (reference) // A61K 9/06 A61K 9/06 GF term (reference) 4C076 AA08 AA12 BB31 CC18 DD37E DD38E DD38F DD43E EE23 EE23A EE54 EE54A EE54E EE58A FF15 FF16 4C083 AA031 AA032 AA111 AA112 AA122 AC022 AC072 AC102 AC122 AC242 AC302 AC352 AC422 AC432 AC482 AC582 AD042 CC03 CC04 CC05 DD22 DD23 DD27 DD31 EE11 EE13 4C088 AA18 AB18A AB18 AB AB51 AB52 AB58 AB59 AB60 AB76 AB77 AB81 AB86 AC01 AC02 AC03 AC04 AC05 AC06 AC11 AC13 AC17 BA04 BA05 BA09 BA10 MA07 MA63 NA14 ZA89 ZB11 ZC13

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】クララ、ホウセンカ、ミントから選ばれる
少なくとも1種以上の抽出エキスと、ヨモギ、当帰、ワ
レモコウ、カンゾウ、アロエ、ヘチマ、オウゴン、海
藻、カミツレ、クチナシ、クマザサ、クワ、シソ、シラ
カバ、スギナ、セイヨウノコギリソウ、ニンジン、ハマ
メリス、バラ、マロニエ、マンネンタケ、トウキセン
カ、ローズマリー、リンゴ、セイヨウキズク、ハトム
ギ、モモ、アンズ、シャクヤク、ショウキョウ、ホウキ
ギ、ボタンピから選ばれる少なくとも1種以上の抽出エ
キスとを配合することを特徴とする皮膚外用剤。
Claims: 1. An extract of at least one selected from Clara, Balsam, and Mint, Artemisia, Toki, Warmoko, Licorice, Aloe, Loofah, Ogon, Seaweed, Chamomile, Gardenia, Kumazasa, Mulberry, Perilla, Birch , Horse chestnut, Achillea millefolium, carrot, hamamelis, rose, marronnier, mannentake, toukisenka, rosemary, apple, pear sword, adlay, peach, apricot, peonies, gingerbread, pear, peanut, buttonpipi and at least one or more extracted extracts An external preparation for skin, characterized by comprising:
JP10230069A 1998-07-30 1998-07-30 Preparation for external use for skin Pending JP2000044481A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10230069A JP2000044481A (en) 1998-07-30 1998-07-30 Preparation for external use for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10230069A JP2000044481A (en) 1998-07-30 1998-07-30 Preparation for external use for skin

Publications (1)

Publication Number Publication Date
JP2000044481A true JP2000044481A (en) 2000-02-15

Family

ID=16902064

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10230069A Pending JP2000044481A (en) 1998-07-30 1998-07-30 Preparation for external use for skin

Country Status (1)

Country Link
JP (1) JP2000044481A (en)

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000297044A (en) * 1999-04-13 2000-10-24 Sunstar Inc Transdermal patch for external use for skin
KR20020088004A (en) * 2001-05-07 2002-11-25 박종문 An toilet composition for protecting and combating blemishes and aging of the skin
JP2003040757A (en) * 2001-07-25 2003-02-13 Nonogawa Shoji Kk Skin care preparation
WO2003015808A1 (en) * 2001-08-16 2003-02-27 Hnat Thomas M Method and composition for treatment of wounds and burns
KR100384661B1 (en) * 2000-12-18 2003-05-22 강삼식 Anti-inflammatory prenylated flavonoid derivatives and extract of Sophora flavescens therewith
JP2003155246A (en) * 2001-11-20 2003-05-27 Fancl Corp Stimulant relief composition
WO2003086432A1 (en) * 2002-04-15 2003-10-23 Tetsuo Santo Therapeutic lotion for dermatitis
WO2003086434A1 (en) * 2002-04-15 2003-10-23 Tetsuo Santo Drinking tea for treating dermatitis
WO2003086433A1 (en) * 2002-04-15 2003-10-23 Tetsuo Santo Therapeutic cream for dermatitis
WO2004009105A1 (en) * 2002-07-18 2004-01-29 Antonio Carlos Pereira Coelho Phytotherapic composition based on vegetable extracts, process for obtainment of said composition and use of vegetable extracts for preparation of a phytotherapic composition
EP1304115A4 (en) * 2000-07-26 2004-07-21 Hououdou Co Ltd Antipruritic compositions and compositions promoting wound healing
WO2002045733A3 (en) * 2000-12-08 2004-10-14 Kyowa Hakko Kogyo Kk Oral preprations having itching-relievign or antipruritic activity
JP2006176436A (en) * 2004-12-22 2006-07-06 Kao Corp SCF expression inhibitor
ES2259274A1 (en) * 2006-05-24 2006-09-16 Francisca Garcia Vizcaino Healing cream is for damaged skin with problems of psoriasis, dermatitis, itching, eczema
EP1707213A1 (en) * 2005-03-17 2006-10-04 Elisabeth Kern Herbal composition for the treatment of cutaneous Erythema
JP2007505151A (en) * 2003-05-25 2007-03-08 杭州浙大力夫生物科技有限公司 Application of bamboo leaf flavone in preventive and therapeutic drugs for prostate diseases and health foods
WO2008044894A1 (en) * 2006-10-12 2008-04-17 Unigen, Inc. Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria
JP2009084222A (en) * 2007-09-28 2009-04-23 Naris Cosmetics Co Ltd Nerve growth factor (NGF) production inhibitor and itching inhibitor external preparation
EP1737475A4 (en) * 2004-03-19 2009-08-05 Xiu-Min Li Herbal therapy for the treatment of asthma
US7645462B2 (en) * 2002-08-27 2010-01-12 3T Herbtech, Inc. Acupoint patch
DE102008002999A1 (en) * 2008-08-12 2010-02-25 Manfred Engels Composition, useful as anticancer or immunostimulants, cosmetics, preferably hair growth- and/or nail care products, dietary supplement and all-purpose cleaners and to treat e.g. gastric ulcers and cold, comprises ginger and chamomile
JP2011219402A (en) * 2010-04-08 2011-11-04 Pola Chemical Industries Inc Pomc production inhibitor
CN103083441A (en) * 2012-11-09 2013-05-08 苗遐 Traditional Chinese medicine scouring bath agent for treating hemorroide gall
CN103316114A (en) * 2013-07-09 2013-09-25 陈静静 Traditional Chinese medicine for treating AS (Ankylosing Spondylitis)
US8568799B2 (en) 2002-03-22 2013-10-29 Unigen, Inc. Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from acacia
US8652535B2 (en) 2002-04-30 2014-02-18 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US8790724B2 (en) 2003-04-04 2014-07-29 Unigen, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
US9061039B2 (en) 2002-03-01 2015-06-23 Unigen, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US9370544B2 (en) 2002-04-30 2016-06-21 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
CN106821859A (en) * 2017-03-16 2017-06-13 上海芝映生物科技有限公司 A kind of preparation method of the composite plant extract liquid with antiallergic itching-relieving action
CN109125207A (en) * 2018-09-21 2019-01-04 广州栋方生物科技股份有限公司 A kind of plant compound of antibacterial anti-acne and its preparation method and application
JP2020007258A (en) * 2018-07-06 2020-01-16 花王株式会社 Antimicrobial peptide expression promoter
CN113208976A (en) * 2020-09-07 2021-08-06 北京工商大学 Skin-firming and nourishing ganoderma lucidum composite fermentation product and preparation method and application thereof
JP7023026B1 (en) 2021-05-18 2022-02-21 株式会社アイビー化粧品 JAK inhibitor

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01102027A (en) * 1987-10-15 1989-04-19 Nitto Denko Corp Production of antiallergic drug
JPH04356423A (en) * 1991-05-31 1992-12-10 Masao Saito Medicated cream and its production
JPH07277939A (en) * 1994-04-05 1995-10-24 Dowa Mining Co Ltd Skin external preparation
JPH07330624A (en) * 1994-06-10 1995-12-19 Sunstar Inc Antiinflammatory and antipruritic agent
JPH0873314A (en) * 1994-09-05 1996-03-19 Ichimaru Pharcos Co Ltd External preparation for skin and bathing agent
JPH0987189A (en) * 1995-09-19 1997-03-31 Ichimaru Pharcos Co Ltd Antiallergic agent containing isodon japonicus hara, paeonia suffruticosa andrews, perilla frutescens britton var. acuta kudo, and/or arunica montana linne
JPH09157176A (en) * 1995-12-05 1997-06-17 Ichimaru Pharcos Co Ltd Antiallergic agent containing extract of hypericum erectum thunb. and tilia miqueliana maxim.
JPH09194385A (en) * 1996-01-10 1997-07-29 Ichimaru Pharcos Co Ltd Antiallergic agent and preparation for external use for skin or bathing agent blended with the same agent
JPH09227390A (en) * 1996-02-19 1997-09-02 Pola Chem Ind Inc Composition for improving skin condition
JPH09255583A (en) * 1996-03-25 1997-09-30 Yamamoto Koryo Kk Antipruritic agent
JPH09291011A (en) * 1996-04-24 1997-11-11 Kose Corp Composition suitable for eternal use
JPH1017461A (en) * 1996-06-28 1998-01-20 Shiseido Co Ltd Preparation for external use for improving skin roughness
JPH10139679A (en) * 1996-11-05 1998-05-26 Noevir Co Ltd Isolation inhibitor of chemical mediator, and cosmetic, medicine and food including the same

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01102027A (en) * 1987-10-15 1989-04-19 Nitto Denko Corp Production of antiallergic drug
JPH04356423A (en) * 1991-05-31 1992-12-10 Masao Saito Medicated cream and its production
JPH07277939A (en) * 1994-04-05 1995-10-24 Dowa Mining Co Ltd Skin external preparation
JPH07330624A (en) * 1994-06-10 1995-12-19 Sunstar Inc Antiinflammatory and antipruritic agent
JPH0873314A (en) * 1994-09-05 1996-03-19 Ichimaru Pharcos Co Ltd External preparation for skin and bathing agent
JPH0987189A (en) * 1995-09-19 1997-03-31 Ichimaru Pharcos Co Ltd Antiallergic agent containing isodon japonicus hara, paeonia suffruticosa andrews, perilla frutescens britton var. acuta kudo, and/or arunica montana linne
JPH09157176A (en) * 1995-12-05 1997-06-17 Ichimaru Pharcos Co Ltd Antiallergic agent containing extract of hypericum erectum thunb. and tilia miqueliana maxim.
JPH09194385A (en) * 1996-01-10 1997-07-29 Ichimaru Pharcos Co Ltd Antiallergic agent and preparation for external use for skin or bathing agent blended with the same agent
JPH09227390A (en) * 1996-02-19 1997-09-02 Pola Chem Ind Inc Composition for improving skin condition
JPH09255583A (en) * 1996-03-25 1997-09-30 Yamamoto Koryo Kk Antipruritic agent
JPH09291011A (en) * 1996-04-24 1997-11-11 Kose Corp Composition suitable for eternal use
JPH1017461A (en) * 1996-06-28 1998-01-20 Shiseido Co Ltd Preparation for external use for improving skin roughness
JPH10139679A (en) * 1996-11-05 1998-05-26 Noevir Co Ltd Isolation inhibitor of chemical mediator, and cosmetic, medicine and food including the same

Cited By (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000297044A (en) * 1999-04-13 2000-10-24 Sunstar Inc Transdermal patch for external use for skin
EP1304115A4 (en) * 2000-07-26 2004-07-21 Hououdou Co Ltd Antipruritic compositions and compositions promoting wound healing
WO2002045733A3 (en) * 2000-12-08 2004-10-14 Kyowa Hakko Kogyo Kk Oral preprations having itching-relievign or antipruritic activity
KR100384661B1 (en) * 2000-12-18 2003-05-22 강삼식 Anti-inflammatory prenylated flavonoid derivatives and extract of Sophora flavescens therewith
KR20020088004A (en) * 2001-05-07 2002-11-25 박종문 An toilet composition for protecting and combating blemishes and aging of the skin
JP2003040757A (en) * 2001-07-25 2003-02-13 Nonogawa Shoji Kk Skin care preparation
WO2003015808A1 (en) * 2001-08-16 2003-02-27 Hnat Thomas M Method and composition for treatment of wounds and burns
US7597911B2 (en) * 2001-08-16 2009-10-06 Curapharm, Inc. Method and composition for treatment of wounds and burns
JP2003155246A (en) * 2001-11-20 2003-05-27 Fancl Corp Stimulant relief composition
US9061039B2 (en) 2002-03-01 2015-06-23 Unigen, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US9168242B2 (en) 2002-03-22 2015-10-27 Unigen, Inc. Isolation of a dual COX-2 and 5-lipdxygenase inhibitor from Acacia
US8568799B2 (en) 2002-03-22 2013-10-29 Unigen, Inc. Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from acacia
JPWO2003086433A1 (en) * 2002-04-15 2005-08-18 哲夫 山東 Dermatitis treatment cream
WO2003086432A1 (en) * 2002-04-15 2003-10-23 Tetsuo Santo Therapeutic lotion for dermatitis
JPWO2003086432A1 (en) * 2002-04-15 2005-08-18 哲夫 山東 Dermatitis lotion
EP1495762A4 (en) * 2002-04-15 2006-04-12 Tetsuo Santo Therapeutic lotion for dermatitis
US7615239B2 (en) 2002-04-15 2009-11-10 Tetsuo Santo Tea for treating dermatitis comprising herbal extracts
WO2003086433A1 (en) * 2002-04-15 2003-10-23 Tetsuo Santo Therapeutic cream for dermatitis
US7572469B2 (en) 2002-04-15 2009-08-11 Tetsuo Santo Therapeutic lotion for dermatitis
JPWO2003086434A1 (en) * 2002-04-15 2005-08-18 哲夫 山東 Drinking tea for dermatitis treatment
WO2003086434A1 (en) * 2002-04-15 2003-10-23 Tetsuo Santo Drinking tea for treating dermatitis
US9655940B2 (en) 2002-04-30 2017-05-23 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
US9370544B2 (en) 2002-04-30 2016-06-21 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
US9849152B2 (en) 2002-04-30 2017-12-26 Unigen, Inc. Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent
US8652535B2 (en) 2002-04-30 2014-02-18 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
WO2004009105A1 (en) * 2002-07-18 2004-01-29 Antonio Carlos Pereira Coelho Phytotherapic composition based on vegetable extracts, process for obtainment of said composition and use of vegetable extracts for preparation of a phytotherapic composition
US7645462B2 (en) * 2002-08-27 2010-01-12 3T Herbtech, Inc. Acupoint patch
US9622964B2 (en) 2003-04-04 2017-04-18 Unigen, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
US8790724B2 (en) 2003-04-04 2014-07-29 Unigen, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
JP2007505151A (en) * 2003-05-25 2007-03-08 杭州浙大力夫生物科技有限公司 Application of bamboo leaf flavone in preventive and therapeutic drugs for prostate diseases and health foods
EP1737475A4 (en) * 2004-03-19 2009-08-05 Xiu-Min Li Herbal therapy for the treatment of asthma
US7854935B2 (en) 2004-03-19 2010-12-21 Herbal Spring, Llc Herbal therapy for the treatment of asthma
EP2532353A1 (en) * 2004-03-19 2012-12-12 Herbs Spring, LLC Herbal therapy for the treatment of asthma
JP2006176436A (en) * 2004-12-22 2006-07-06 Kao Corp SCF expression inhibitor
EP1707213A1 (en) * 2005-03-17 2006-10-04 Elisabeth Kern Herbal composition for the treatment of cutaneous Erythema
ES2259274A1 (en) * 2006-05-24 2006-09-16 Francisca Garcia Vizcaino Healing cream is for damaged skin with problems of psoriasis, dermatitis, itching, eczema
ES2259274B2 (en) * 2006-05-24 2007-03-16 Francisca Garcia Vizcaino REPAIR CREAM FOR DAMAGED SKIN.
WO2008044894A1 (en) * 2006-10-12 2008-04-17 Unigen, Inc. Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria
CN101616681B (en) * 2006-10-12 2013-07-10 株式会社优力竟 Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria
US8247007B2 (en) 2006-10-12 2012-08-21 Unigen, Inc. Composition for treating atopic dermatitis comprising extracts of bamboo and Scutellaria
US8771761B2 (en) 2006-10-12 2014-07-08 Unigen, Inc. Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria
JP2010505944A (en) * 2006-10-12 2010-02-25 ユニジェン インク. Composition for the treatment of atopic dermatitis containing bamboo extract and Koganebana extract
AU2007307427B2 (en) * 2006-10-12 2013-05-09 Unigen, Inc. Composition for treating atopic dermatitis comprising extracts of Bamboo and Scutellaria
US9623068B2 (en) 2006-10-12 2017-04-18 Unigen, Inc. Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria
JP2009084222A (en) * 2007-09-28 2009-04-23 Naris Cosmetics Co Ltd Nerve growth factor (NGF) production inhibitor and itching inhibitor external preparation
DE102008002999A1 (en) * 2008-08-12 2010-02-25 Manfred Engels Composition, useful as anticancer or immunostimulants, cosmetics, preferably hair growth- and/or nail care products, dietary supplement and all-purpose cleaners and to treat e.g. gastric ulcers and cold, comprises ginger and chamomile
JP2011219402A (en) * 2010-04-08 2011-11-04 Pola Chemical Industries Inc Pomc production inhibitor
CN103083441A (en) * 2012-11-09 2013-05-08 苗遐 Traditional Chinese medicine scouring bath agent for treating hemorroide gall
CN103316114A (en) * 2013-07-09 2013-09-25 陈静静 Traditional Chinese medicine for treating AS (Ankylosing Spondylitis)
CN106821859A (en) * 2017-03-16 2017-06-13 上海芝映生物科技有限公司 A kind of preparation method of the composite plant extract liquid with antiallergic itching-relieving action
JP2020007258A (en) * 2018-07-06 2020-01-16 花王株式会社 Antimicrobial peptide expression promoter
JP7138496B2 (en) 2018-07-06 2022-09-16 花王株式会社 Antimicrobial peptide expression promoter
CN109125207A (en) * 2018-09-21 2019-01-04 广州栋方生物科技股份有限公司 A kind of plant compound of antibacterial anti-acne and its preparation method and application
CN113208976A (en) * 2020-09-07 2021-08-06 北京工商大学 Skin-firming and nourishing ganoderma lucidum composite fermentation product and preparation method and application thereof
JP7023026B1 (en) 2021-05-18 2022-02-21 株式会社アイビー化粧品 JAK inhibitor
JP2022177590A (en) * 2021-05-18 2022-12-01 株式会社アイビー化粧品 JAK inhibitor

Similar Documents

Publication Publication Date Title
JP2000044481A (en) Preparation for external use for skin
EP2278986B1 (en) A product for topical administration
US6395311B2 (en) Multicomponent biological vehicle
JPH10130162A (en) Hyaluronic acid decomposition inhibitor, agent for treatment of hyaluronic acid abnormal decomposition disease and cosmetic
CN113521164B (en) Tibetan medicine composition with antibacterial effect and preparation method and application thereof
KR20140071738A (en) Cosmetic composition for alleviating dermatitis and skin irritation
CN111281966B (en) Composition containing earthworm protein, preparation method and application thereof
CN114432225A (en) Sunscreen skin care product and preparation method thereof
CN112022767B (en) Anti-inflammatory antibacterial immunity-enhancing acne-removing composition and application thereof
WO2006043771A1 (en) Composition comprising extract of anemarrhena asphodeloides and aralia elata, and use thereof
KR20060083567A (en) Herbal cosmetic composition for atopic skin containing specific herbal extract mixture
ES2394316T3 (en) Pharmaceutical compositions of Carapa Guianensis.
CN111789799A (en) Plant composition with red-removing, anti-inflammatory and relieving effects and application thereof
CN106620633A (en) Skin repairing cream for tumor patients and preparation method of skin repairing cream
KR20090126992A (en) Camellia gourd (camellia seed shell powder) and its use
CN108853249A (en) It is a kind of to treat dermopathic plastics
KR20110121295A (en) External skin composition for relieving menstrual pain
KR20060074038A (en) Composition having a prophylactic effect of atopic dermatitis
KR100644086B1 (en) Method of manufacturing herbal baths without skin irritation
JP5030366B2 (en) Composition for treatment of allergic diseases
KR100820343B1 (en) Compositions for treating inflammatory dermatological disease
CN104940524B (en) It is a kind of to be used to treat drug of leucoderma and preparation method thereof
KR20030092519A (en) Composition for improving or preventing of allergic dermatological diseases
Oladele et al. Evaluation of anti-inflammatory and membrane stabilizing effects of aqueous root extract of Boerhavia diffusa Linn. in rats
Ray Scope of Aloe vera as Medicinal Plant and skin care

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20060228

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060307

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060427

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070807